DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» OrbiMed
OrbiMed
RRP Sector Assessment
Orbimed Partners
Israel's Life Sciences Industry IATI Report 2017
Orbimed Launches $924 Million Royalty & Credit Opportunities Fund
Orbimed Asia Partners III, L.P. Form D/A Filed 2017-09-06
OTONOMY, INC. (Name of Issuer)
3Rd FCF Life Science Venture Capital Report
FCF Life Science Venture Capital Monitor
Orbimed Announces New General Partner
Private Equity Analyst
Semi-Annual Market Review
May 9, 2018 Orbimed Announces New General Partner
A Primer for Development Finance and Philanthropic Funders
Dingdang Health Raises $220 Million in New Financing Round Led by TPG June 8, 2021, Beijing
Orbimed Launches $551 Million Asia Private Equity Fund
Valneva Announces Amendment to Deerfield and Orbimed Debt Facility Terms
Ourcrowd Named Most Active Venture Investor in Israel by Pitchbook Largest in Israel Since 2016 with Over 30 Deals
European Life Sciences Start-Ups Maintain Early Investor Allure
Top View
May 23, 2016 Orbimed Launches $307 Million Israel Venture Capital Fund
Orbimed Advisors Offers 'One-Stop Shop' for Health-Care Companies
Orbimed Launches $735 Million Venture Capital Fund
Prevail Therapeutics Announces $75 Million Series a Financing to Advance Gene Therapies for Patients with Parkinson’S and Other Neurodegenerative Diseases
Private Equity Summary 2015Report Benesch Health Care Market Intelligence
Largest Funds Closed in Q1 2015 by Region
Orbimed Supports the Proposed Foamix Pharmaceuticals Ltd. and Menlo Therapeutics Inc
Follow-On Investment in Orbimed Asia Partners IV: Sector Overview
The Biotech Startup Class of 2013: Don’T Worry, It’S a Short List Luke Timmerman | 10/18/13
Orbimed Partners
Private Equity Firms
Orbimed Partners
Valneva Announces Amendment to Deerfield and Orbimed Debt Facility Terms
Canadian Private Equity Buyout Review
International Corporate Finance M&A • Private Equity • Banking & Finance • Tax • Antitrust
Aerocrine Completes USD 50 Million Debt and Equity Financing
Item 14 MEETING DATE: June 17, 2020
Mar 1, 2021 Orbimed Raises $3.5 Billion Across Private Investment